MedPath

AMNEAL PHARMACEUTICALS LLC

🇺🇸United States
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://amneal.com

Clinical Trials

9

Active:0
Completed:6

Trial Phases

1 Phases

Not Applicable:5

Drug Approvals

418

FDA:418

Drug Approvals

Testosterone

Approval Date
Jul 12, 2025
FDA

PEMRYDI RTU

Approval Date
Jul 8, 2025
FDA

doxycycline hyclate

Approval Date
Jun 30, 2025
FDA

brexpiprazole

Approval Date
Jun 27, 2025
FDA

Methylergonovine Maleate

Approval Date
Jun 12, 2025
FDA

LOTEPREDNOL ETABONATE

Approval Date
May 21, 2025
FDA

Pilocarpine Hydrochloride Ophthalmic

Approval Date
May 2, 2025
FDA

CREXONT

Approval Date
Feb 12, 2025
FDA

Temozolomide

Approval Date
Apr 4, 2024
FDA

Fosfomycin Tromethamine

Approval Date
Apr 2, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 42
  • Next

Clinical Trials

Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials

Not Applicable
5 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.